Drugs Made in America Acquisition Ii CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Drugs Made In America Acquisition II Corp.'s sponsor and CEO, Lynn Stockwell, jointly reported a beneficial ownership of 10.2% of the company's ordinary shares.